These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9665203)

  • 1. In vitro excess ammonia production in human myeloma cell lines.
    Otsuki T; Yamada O; Sakaguchi H; Ichiki T; Kouguchi K; Wada H; Hata H; Yawata Y; Ueki A
    Leukemia; 1998 Jul; 12(7):1149-58. PubMed ID: 9665203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
    Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
    Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia.
    Matsuzaki H; Matsuno F; Yoshida M; Hata H; Okazaki K; Takatsuki K
    Intern Med; 1992 Mar; 31(3):339-43. PubMed ID: 1611184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
    Otsuki T; Wada H; Nakazawa N; Taniwaki M; Kouguchi K; Ohkura M; Uehira K; Isoda K; Yata K; Sakaguchi H; Yawata Y; Ueki A; Yamada O
    Leuk Lymphoma; 2001 Aug; 42(4):761-74. PubMed ID: 11697507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of interleukin 6 production by reverse transcriptase-polymerase chain reaction in four human myeloma cell lines.
    Suzuki A; Takahashi T; Okuno Y; Fukumoto M; Fukui H; Koishihara Y; Ohsugi Y; Ohno Y; Imura H
    Leuk Res; 1991; 15(11):1043-50. PubMed ID: 1720489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ornithine transcarbamylase present in mycoplasma-infected myeloma cells.
    Matsuno F; Matsuzaki H; Akahoshi Y; Yoshida M; Hata H; Takiguchi M; Takatsuki K; Mori M
    Enzyme Protein; 1993; 47(2):57-64. PubMed ID: 8193671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
    Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
    Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological study of multiple myeloma associated with hyperammonemia].
    Fujii S; Fukuda S; Sezaki T; Murakami M
    Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular calcium Ca2+o-sensing receptor is expressed in myeloma cells and modulates cell proliferation.
    Yamaguchi T; Yamauchi M; Sugimoto T; Chauhan D; Anderson KC; Brown EM; Chihara K
    Biochem Biophys Res Commun; 2002 Dec; 299(4):532-8. PubMed ID: 12459170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
    Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
    Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
    J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
    Jernberg H; Pettersson M; Kishimoto T; Nilsson K
    Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.